Treatment of heavy menstrual bleeding of endometrial origin: Randomized controlled trial of medroxyprogesterone acetate and tranexamic acid

Archives of Gynecology and Obstetrics

Volumn 288, Issue 5, 2013, Pages 1055-1060

  Goshtasebi, Azita ^a   Moukhah, Somayeh ^b   Gandevani, Samira Behboudi ^b  

^a Iranian Institute for Health Sciences Research   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Heavy menstrual bleeding of endometrial origin; medroxyprogesterone acetate; Randomized controlled trial; Tranexamic acid

Indexed keywords

FERRITIN; HEMOGLOBIN; MEDROXYPROGESTERONE ACETATE; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; BREAST TENDERNESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ENDOMETRIUM; FEMALE; FERRITIN BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MENORRHAGIA; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 36; SPOTTING; VERTIGO;

ADULT; ANTIFIBRINOLYTIC AGENTS; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIUM; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MENORRHAGIA; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TRANEXAMIC ACID; YOUNG ADULT;

EID: 84886092204     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2839-3     Document Type: Article

References (22)

1. Philipp CS (2011) Antifibrinolytics in women with HMB. Thromb Res 127(Suppl 3):S113-S115
2. Srinil S, Jaisamrarn U (2005) Treatment of heavy menstrual bleeding of endometrial origin with tranexamic acid. Med Assoc Thail 88:1
3. Marret H, Fauconnier A, Chabbert-Buffet N, Cravello L, Golfier F, Gondry J et al (2010) Clinical practice guidelines on HMB: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 152(2):133-137
4. Freeman EW, Lukes A, VanDrie D, Mabey RG, Gersten J, Adomako TL (2011) A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding. Am J Obstet Gynecol 205(4):319 e1-319.e7
5. Munro MG et al (2011) FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 113(1):3-13
6. Bushnell DM, Martin ML, Moore KA, Richter HE, Rubin A, Patrick DL (2010) HMB impact questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Curr Med Res Opin 0:2745-2755
7. National Institute for Health and Clinical Excellence (2007) Heavy menstrual bleeding. National Institute for Health and Clinical Excellence (NICE). Clinical Guideline 44. London
8. Lukes AS, Freeman EW, Van Drie D, Baker J, Adomako TL (2011) Safety of tranexamic acid in women with heavy menstrual bleeding: an open-label extension study. Womens Health (Lond Engl) 7(5):591-598
9. ® use. Contraception 73(3):253-256
10. Wellington K, Wagstaff AJ (2003) Tranexamic acid: a review of its use in the management of HMB. Drugs 63(13):1417-1433
11. Lethaby A, Irvine G, Cameron I (2008) Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 23(1):CD001016. doi: 10.1002/14651858.CD001016.pub2
12. Kucuk T, Ertan K (2008) Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal HMB: a randomized, prospective, controlled clinical trial in female smokers. Clin Exper Obstet Gynaecol 35(1):57-60
13. Kriplani A, Kulshrestha V, Agarwal N, Diwakar S (2006) Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol 26(7):673-678
14. Keppel G Wickens TD (2007) Design and analysis, Prentice Hall, NJ
15. Janssen CA, Scholten PC, Heintz AP (1995) A simple visual assessment technique to discriminate between HMB and normal menstrual blood loss. Obstet Gynecol 85(6):977-982
16. Zakherah MS, Sayed GH, El-Nashar SA, Shaaban MM (2011) Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest 71(4):281-284
17. Mazari Z, Goshtasebi A, Moukhah S, Saki F (2011) HMB Questionnaire (MQ): translation and validation study of the Iranian version. Payesh 11:83-88
18. Ruta DA, Garratt AM, Chadha YC, Flett GM, Hall MH, Russell IT (1995) Assessment of patients with HMB: how valid is a structured clinical history as a measure of health status? Qual Life Res 4(1):33-40
19. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B (2005) The short form health survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 14(3):875-882
20. Bubbar VK, Kreder HJ (2006) The intention-to-treat principle: a primer for the orthopaedic surgeon. J Bone Joint Surg Am 88(9):2097-2099
21. Preston JT, Cameron IT, Adams EJ, Smith SK (1995) Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory HMB. BJOG 102(5):401-406
22. Naoulou B, Tsai MC (2012) Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand 91(5):529-537